BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33959190)

  • 1. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma.
    Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H
    Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
    Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
    J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
    Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
    BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into clear cell renal cell carcinoma prognosis by comprehensive characterization of aberrant alternative splicing signature: a study based on large-scale sequencing data.
    Zhang D; Zhang W; Sun R; Huang Z
    Bioengineered; 2021 Dec; 12(1):1091-1110. PubMed ID: 33783315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
    Zhan Y; Guo W; Zhang Y; Wang Q; Xu XJ; Zhu L
    Comput Math Methods Med; 2015; 2015():842784. PubMed ID: 26539246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma.
    Xing Q; Ji C; Zhu B; Cong R; Wang Y
    Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
    Duan Y; Zhang D
    J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.
    Yin L; Li W; Wang G; Shi H; Wang K; Yang H; Peng B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):343. PubMed ID: 31391070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data.
    Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q
    Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
    Chen L; Xiang Z; Chen X; Zhu X; Peng X
    Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
    Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster of metabolism-related genes predict prognosis and progression of clear cell renal cell carcinoma.
    Liu M; Pan Q; Xiao R; Yu Y; Lu W; Wang L
    Sci Rep; 2020 Jul; 10(1):12949. PubMed ID: 32737333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
    Lai J; Yang H; Xu T
    BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma.
    Tang W; Cao Y; Ma X
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.